Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Clinical trial finds vitamin D does not ward off colds and flu
Clinical trial finds vitamin D does not ward off colds and flu
A QIMR Berghofer-led randomised controlled trial of vitamin D supplements has found they do not protect most people from developing colds, flus and other acute respiratory infections.
Monash University leads breakthrough against antibiotic-resistance
Monash University leads breakthrough against antibiotic-resistance
A major risk of being hospitalised is catching a bacterial infection.
EU approval for ViiV’s Tivicay for children living with HIV
EU approval for ViiV’s Tivicay for children living with HIV
ViiV Healthcare has bagged a marketing authorisation for a dispersible tablet formulation of its HIV-1 treatment Tivicay (dolutegravir) in paediatric patients aged at least four weeks and weig...
Gilead and Vir unite to find a ‘functional cure’ for hepatitis B
Gilead and Vir unite to find a ‘functional cure’ for hepatitis B
Gilead Sciences and Vir Biotechnology have partnered to evaluate novel therapeutic combination strategies aimed at developing a ‘functional cure’ for chronic hepatitis B virus (HBV).
Johnson & Johnson's COVID-19 vaccine production lags goals as data readout nears: NYT
Johnson & Johnson's COVID-19 vaccine production lags goals as data readout nears: NYT
Amid slower than expected rollouts for the Pfizer and Moderna COVID-19 vaccines in the U.
Sanofi to Buy Antibody Maker Kymab in $1.45 Billion Deal
Sanofi to Buy Antibody Maker Kymab in $1.45 Billion Deal
Sanofi agreed to buy the U.
Chinese researchers develop new enzyme to treat neuroinflammation
Chinese researchers develop new enzyme to treat neuroinflammation
TIANJIN, Jan.
Lilly hails Alzheimer's win with donanemab, boasting 'significant slowing of decline'
Lilly hails Alzheimer's win with donanemab, boasting 'significant slowing of decline'
The amyloid theory continues to grasp at life as Eli Lilly has unveiled new phase 2 data from donanemab that show it can help Alzheimer’s disease patients by clearing these plaques out of the brain.
Gilead Updates 2020 Guidance with Post-Holiday COVID-19 Spike
Gilead Updates 2020 Guidance with Post-Holiday COVID-19 Spike
Gilead Sciences’ Veklury, which is better known by its scientific name remdesivir, is the only antiviral drug currently approved to treat COVID-19.
Several gorillas test positive for COVID-19 at California zoo—first in the world
Several gorillas test positive for COVID-19 at California zoo—first in the world
Three western lowland gorillas at the San Diego Zoo Safari Park have tested positive for the coronavirus, the U.
FDA approves avapritinib for gastrointestinal stromal tumor with a rare mutation
FDA approves avapritinib for gastrointestinal stromal tumor with a rare mutation
On January 9, 2020, the Food and Drug Administration approved avapritinib (AYVAKITTM, Blueprint Medicines Corporation) for adults with unresectable or metastatic gastrointestinal stromal tumor...
FDA Grants Priority Review to Dapagliflozin for CKD
FDA Grants Priority Review to Dapagliflozin for CKD
The FDA decision on dapaglifozin for CKD is expected in the second quarter of 2021.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand